miRNA Expression in Aneurysm Healing


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-002144
    Sponsor Protocol Number: 16-002144

About this study

The purpose of this study is to determine if vascular remodeling may be impacted by concomitant coiling with flow diverter therapy. We will compare micro-RNA markers between groups of patients treated with and without concomitant coiling with flow diversion therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Patients with Aneurysms is one of the following groups:
    • Group 1- Aneurysms treated with flow diverters alone
    • Group 2- Aneurysms treated with platinum coils alone
    • Group 3- Aneurysms treated with flow diverters and concomitant coiling
  • Age 21-80

Exclusion Criteria:

  • Pregnant women
  • Children
  • Vulnerable subjects


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ramanathan Kadirvel, Ph.D.

Open for enrollment

Contact information:

Ann Nielsen R.N.




Mayo Clinic Footer